Follow this preprint
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study
View ORCID ProfileMaria Krutikov, Tom Palmer, View ORCID ProfileGokhan Tut, Christopher Fuller, Borscha Azmi, Rebecca Giddings, View ORCID ProfileMadhumita Shrotri, Nayandeep Kaur, Panagiota Sylla, Tara Lancaster, Aidan Irwin-Singer, View ORCID ProfileAndrew Hayward, Paul Moss, Andrew Copas, View ORCID ProfileLaura Shallcross
doi: https://doi.org/10.1101/2021.09.27.21264166
Now published in The Lancet Healthy Longevity doi: 10.1016/S2666-7568(21)00282-8
Maria Krutikov
1UCL Institute of Health Informatics, London, UK
MRCPTom Palmer
2UCL Institute for Global Health, London, UK
MScGokhan Tut
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
PhDChristopher Fuller
1UCL Institute of Health Informatics, London, UK
MScBorscha Azmi
1UCL Institute of Health Informatics, London, UK
MScRebecca Giddings
1UCL Institute of Health Informatics, London, UK
MFPHMadhumita Shrotri
1UCL Institute of Health Informatics, London, UK
MFPHNayandeep Kaur
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
MScPanagiota Sylla
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
MScTara Lancaster
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
PhDAidan Irwin-Singer
6Department of Health and Social Care, London, UK
MAAndrew Hayward
3UCL Institute of Epidemiology & Health Care
5Health Data Research UK
MDPaul Moss
4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
PhDAndrew Copas
2UCL Institute for Global Health, London, UK
PhDLaura Shallcross
1UCL Institute of Health Informatics, London, UK
PhD
Posted September 29, 2021.
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibody in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study
Maria Krutikov, Tom Palmer, Gokhan Tut, Christopher Fuller, Borscha Azmi, Rebecca Giddings, Madhumita Shrotri, Nayandeep Kaur, Panagiota Sylla, Tara Lancaster, Aidan Irwin-Singer, Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross
medRxiv 2021.09.27.21264166; doi: https://doi.org/10.1101/2021.09.27.21264166
Now published in The Lancet Healthy Longevity doi: 10.1016/S2666-7568(21)00282-8
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3174)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13144)
- Forensic Medicine (17)
- Gastroenterology (878)
- Genetic and Genomic Medicine (4977)
- Geriatric Medicine (458)
- Health Economics (761)
- Health Informatics (3131)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (462)
- Medical Ethics (121)
- Nephrology (511)
- Neurology (4724)
- Nursing (250)
- Nutrition (699)
- Oncology (2433)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (315)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1263)
- Primary Care Research (536)
- Public and Global Health (7294)
- Radiology and Imaging (1634)
- Respiratory Medicine (953)
- Rheumatology (468)
- Sports Medicine (409)
- Surgery (527)
- Toxicology (66)
- Transplantation (225)
- Urology (196)